Quince Therapeutics, Inc. (QNCX)
0.0875
-0.01
(-11.62%)
USD |
NASDAQ |
Apr 06, 16:00
0.096
+0.01
(+9.71%)
After-Hours: 05:53
Quince Therapeutics SG&A Expense (TTM) : 15.70M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | 176.59M |
| Ocular Therapeutix, Inc. | 118.30M |
| Gossamer Bio, Inc. | 37.63M |
| Ernexa Therapeutics, Inc. | 5.162M |
| Acurx Pharmaceuticals, Inc. | 6.230M |